Equity Research, Broker Reports, and media content on ESPERITE

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about ESPERITE
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on ESPERITE. We currently have 0 research reports from 0 professional analysts.

Open
1.30
Volume
0.1m
Range
1.30/1.30
Market Cap
13,571,083m
52 Week
1.20/2.80
Date Source Announcement
10Mar17 13:29 GNW Esperite N.V. convenes Extraordinary General Meeting of Shareholders regarding external financing of up to EUR 13 million
08Mar17 07:26 GNW Esperite secures external financing of up to EUR 9 million to support its commercial activity and development of innovative technologies
08Mar17 06:17 GNW Esperite secures external financing of up to EUR 9 million to support its commercial activity and development of innovative technologies
28Feb17 07:55 GNW Esperite N.V.: Update on Financing
31Dec16 06:17 GNW Esperite N.V.: Update on Financing
08Nov16 06:17 GNW Esperite N.V. : Stem Cells, Genetic Tests and Pharmaceuticals
20Oct16 06:17 GNW Esperite N.V. (ESP) expands extracellular vesicles (exosomes) products portfolio to include inflammatory bowel disease. The Cell Factory develops therapy for Crohn's disease.
  • Frequency of research reports

     

  • Research reports on

    ESPERITE

  • Providers covering

    ESPERITE